{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:28:42Z","timestamp":1768076922991,"version":"3.49.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.joms.2017.04.017","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:17:00Z","timestamp":1493165820000},"page":"2354-2368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Preventive Effect of Phosphodiesterase Inhibitor Pentoxifylline Against Medication-Related Osteonecrosis of the Jaw: An Animal Study"],"prefix":"10.1016","volume":"75","author":[{"given":"G\u00fcl Merve","family":"Yalcin-Ulker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alev","family":"Cumbul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonca","family":"Duygu-Capar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dcnal","family":"Uslu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Sencift","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 12","key":"10.1016\/j.joms.2017.04.017_bib1","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2017.04.017_bib2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"Medication-related osteonecrosis of the jaw\u20142014 Update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2017.04.017_bib3","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","article-title":"Bisphosphonate action: Alendronate localization in rat bone osteoclast ultrastructure","volume":"88","author":"Sato","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.joms.2017.04.017_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/8756-3282(96)00182-2","article-title":"Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones","volume":"19","author":"Masarachia","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.joms.2017.04.017_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF02555852","article-title":"Inhibition of bone resorption by bisphosphonates: Interactions between bisphosphonates, osteoclasts, and bone","volume":"49","author":"Flanagan","year":"1991","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.joms.2017.04.017_bib6","first-page":"27","article-title":"Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix","volume":"1","author":"Boonekamp","year":"1986","journal-title":"Bone Miner"},{"key":"10.1016\/j.joms.2017.04.017_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002239900519","article-title":"Alendronate reduces adhesion of human osteoclast-like cells to bone and bone protein-coated surfaces","volume":"63","author":"Colucci","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.joms.2017.04.017_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF00316291","article-title":"The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number","volume":"54","author":"Piper","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.joms.2017.04.017_bib9","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in\u00a0vitro and in\u00a0vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2017.04.017_bib10","doi-asserted-by":"crossref","first-page":"34967","DOI":"10.1074\/jbc.274.49.34967","article-title":"Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase","volume":"274","author":"Reszka","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.joms.2017.04.017_bib11","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in\u00a0vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.joms.2017.04.017_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.cad.0000198909.52701.0f","article-title":"A new dimethyl ester bisphosphonate inhibits angiogenesis and growth of human epidermoid carcinoma xenograft in nude mice","volume":"17","author":"Ledoux","year":"2006","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.joms.2017.04.017_bib13","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenic factors in cancer patients","volume":"8","author":"Santini","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2017.04.017_bib14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/annonc\/mdg194","article-title":"Bisphosphonates: New antiangiogenic molecules in cancer treatment?","volume":"14","author":"Vincenzi","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.joms.2017.04.017_bib15","first-page":"237","article-title":"Effect of pamidronate on bone blood flow in oophorectomized rats","volume":"47","author":"Kapitola","year":"1998","journal-title":"Physiol Res"},{"key":"10.1016\/j.joms.2017.04.017_bib16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1182\/blood-2009-08-237628","article-title":"Osteoclasts are important for bone angiogenesis","volume":"115","author":"Cackowski","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.joms.2017.04.017_bib17","first-page":"53","article-title":"Increase of bone blood flow, an initial step of bone demineralization in the rat","volume":"36","author":"Schoutens","year":"1984","journal-title":"Calcif Tissue Int"},{"issue":"suppl 4","key":"10.1016\/j.joms.2017.04.017_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1634\/theoncologist.9-90004-28","article-title":"Safety of intravenous and oral bisphosphonates and compliance with dosing regimens","volume":"9","author":"Conte","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.joms.2017.04.017_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2249.2005.02665.x","article-title":"The bisphosphonate acute phase response: Rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to amino bisphosphonates is inhibited by statins","volume":"139","author":"Hewitt","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.joms.2017.04.017_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1523-1755.2003.00071.x","article-title":"Toxic acute tubular necrosis following treatment with zoledronate (Zometa)","volume":"64","author":"Markowitz","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.joms.2017.04.017_bib21","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2017.04.017_bib22","first-page":"1015","article-title":"Ocular side effects of bisphosphonates: A case report and literature review","volume":"56","author":"McKague","year":"2010","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.joms.2017.04.017_bib23","doi-asserted-by":"crossref","first-page":"E431","DOI":"10.1503\/cmaj.111752","article-title":"Inflammatory ocular adverse events with the use of oral bisphosphonates: A retrospective cohort study","volume":"184","author":"Etminan","year":"2012","journal-title":"CMAJ"},{"key":"10.1016\/j.joms.2017.04.017_bib24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2017.04.017_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2017.04.017_bib26","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 Update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2017.04.017_bib27","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1177\/0022034510378427","article-title":"Osteogenic potential of mandibular vs. long-bone marrow stromal cells","volume":"89","author":"Aghaloo","year":"2010","journal-title":"J\u00a0Dent Res"},{"key":"10.1016\/j.joms.2017.04.017_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpor.2014.08.001","article-title":"Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab","volume":"59","author":"Niibe","year":"2015","journal-title":"J Prosthodont Res"},{"key":"10.1016\/j.joms.2017.04.017_bib29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/adj.12217","article-title":"Denosumab and osteonecrosis of the jaws\u2014The pharmacology, pathogenesis and a report of two cases","volume":"59","author":"O'Halloran","year":"2014","journal-title":"Aust Dent J"},{"key":"10.1016\/j.joms.2017.04.017_bib30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.12968\/denu.2014.41.5.449","article-title":"Denosumab-associated osteonecrosis of the jaw\u2014A case report","volume":"41","author":"Vyas","year":"2014","journal-title":"Dent Update"},{"key":"10.1016\/j.joms.2017.04.017_bib31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1177\/039463200902200429","article-title":"Bevacizumab-related osteonecrosis of the jaw","volume":"22","author":"Serra","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.joms.2017.04.017_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10549-010-0933-9","article-title":"Osteonecrosis of the jaw and bevacizumab therapy","volume":"122","author":"Van Poznak","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.joms.2017.04.017_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10006-010-0224-y","article-title":"Osteonecrosis of the jaw related to sunitinib","volume":"15","author":"Koch","year":"2011","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2017.04.017_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","article-title":"Pentoxifylline: A review of its pharmacodynamics and pharmacokinetic properties, and its therapeutic efficacy","volume":"34","author":"Ward","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.joms.2017.04.017_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S8756-3282(00)00450-6","article-title":"Enhancement of bone morphogenetic protein-2\u2013induced new bone formation in mice by the phosphodiesterase inhibitor pentoxifylline","volume":"28","author":"Horiuchi","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.joms.2017.04.017_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1043-6618(03)00002-1","article-title":"The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat","volume":"47","author":"Abdel-Salam","year":"2003","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.joms.2017.04.017_bib37","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2006.11.032","article-title":"Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease\u2014A randomized placebo-controlled study","volume":"196","author":"Fernandes","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.joms.2017.04.017_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1006\/cimm.1996.0184","article-title":"The regulation of tumor necrosis factor-alpha production in murine mast cells: Pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms","volume":"171","author":"Schmidt-Choudhury","year":"1996","journal-title":"Cell Immunol"},{"key":"10.1016\/j.joms.2017.04.017_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2567.1997.00252.x","article-title":"Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-1 beta IL-10 by human leucocytes","volume":"91","author":"van Furth","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.joms.2017.04.017_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0171-2985(11)80356-6","article-title":"Inhibition of endogenous TNF formation by pentoxifylline","volume":"187","author":"Zabel","year":"1993","journal-title":"Immunobiology"},{"key":"10.1016\/j.joms.2017.04.017_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejphar.2004.06.003","article-title":"Tumour necrosis factor-alpha mediates neutrophil migration to the knee synovial cavity during immune inflammation","volume":"496","author":"Bombini","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.joms.2017.04.017_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.lfs.2013.07.022","article-title":"Preventive and therapeutic anti\u2013TNF-\u03b1 therapy with pentoxifylline decreases arthritis and the associated periodontal co-morbidity in mice","volume":"93","author":"Queiroz-Junior","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.joms.2017.04.017_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.moo.0000170527.59017.ff","article-title":"Osteoradionecrosis of the mandible","volume":"13","author":"Teng","year":"2005","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.joms.2017.04.017_bib44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S8756-3282(02)00839-6","article-title":"A phosphodiesterase inhibitor, pentoxifylline, enhances the bone morphogenetic protein-4 (BMP-4)-dependent differentiation of osteoprogenitor cells","volume":"31","author":"Tsutsumimoto","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.joms.2017.04.017_bib45","first-page":"160","article-title":"Effect of pentoxifylline on fracture healing: An experimental study","volume":"22","author":"Aydin","year":"2011","journal-title":"Eklem Hastalik Cerrahisi"},{"key":"10.1016\/j.joms.2017.04.017_bib46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.oooo.2013.11.490","article-title":"Does an alkaline environment prevent the development of bisphosphonate-related osteonecrosis of the jaw? An experimental study in rats","volume":"117","author":"Dayisoylu","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.joms.2017.04.017_bib47","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0720-048X(03)00077-9","article-title":"Rapid estimation of the vertebral body volume: A combination of the Cavalieri principle and computed tomography images","volume":"48","author":"Odaci","year":"2003","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.joms.2017.04.017_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J Microsc"},{"key":"10.1016\/j.joms.2017.04.017_bib49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ajodo.2016.05.016","article-title":"Effects of local platelet-rich plasma injection on the rate of orthodontic tooth movement in a rat model: A histomorphometric study","volume":"151","author":"G\u00fcle\u00e7","year":"2017","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"10.1016\/j.joms.2017.04.017_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1746-6148-9-123","article-title":"Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology\u2014A systematic review","volume":"9","author":"Klopfleisch","year":"2013","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.joms.2017.04.017_bib51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.lfs.2011.07.005","article-title":"The effect of phosphodiesterase-5 inhibition by sildenafil citrate on inflammation and apoptosis in rat experimental colitis","volume":"89","author":"Karakoyun","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.joms.2017.04.017_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","article-title":"Bisphosphonate-related osteonecrosis of the jaws\u2014Characteristics, risk factors, clinical features, localization and impact on oncological treatment","volume":"40","author":"Otto","year":"2012","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2017.04.017_bib53","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jbmr.23","article-title":"Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats","volume":"25","author":"Hokugo","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2017.04.017_bib54","doi-asserted-by":"crossref","first-page":"e879","DOI":"10.4317\/medoral.17150","article-title":"Extraction socket healing in rats treated with bisphosphonate: Animal model for bisphosphonate related osteonecrosis of jaws in multiple myeloma patients","volume":"16","author":"Ali-Erdem","year":"2011","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.joms.2017.04.017_bib55","first-page":"693","article-title":"Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs","volume":"22","author":"Allen","year":"2011","journal-title":"Osteoporos\u00a0Int"},{"key":"10.1016\/j.joms.2017.04.017_bib56","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1600-0714.2009.00878.x","article-title":"A novel animal model to study nonspontaneous bisphosphonates osteonecrosis of jaw","volume":"35","author":"Biasotto","year":"2010","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.joms.2017.04.017_bib57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tripleo.2009.10.011","article-title":"Jaw bone changes in rats after treatment with zoledronate and pamidronate","volume":"109","author":"Senel","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2017.04.017_bib58","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jcms.2013.11.005","article-title":"Zoledronic acid\u2013related osteonecrosis of the jaws. Experimental model with dental extractions in rats","volume":"42","author":"Barba-Recreo","year":"2014","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2017.04.017_bib59","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00774-009-0090-6","article-title":"Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats","volume":"27","author":"Hikita","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.joms.2017.04.017_bib60","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.archoralbio.2009.06.002","article-title":"Zoledronic acid decreases bone formation without causing osteocyte death in mice","volume":"54","author":"Huja","year":"2009","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.joms.2017.04.017_bib61","doi-asserted-by":"crossref","first-page":"20130144","DOI":"10.1259\/dmfr.20130144","article-title":"Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: A rat model","volume":"43","author":"Ersan","year":"2014","journal-title":"Dentomaxillofac Radiol"},{"key":"10.1016\/j.joms.2017.04.017_bib62","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1600-0714.2012.01140.x","article-title":"Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds\u2014Histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation","volume":"41","author":"Vasconcelos","year":"2012","journal-title":"J Oral Pathol Med"},{"issue":"Spec No","key":"10.1016\/j.joms.2017.04.017_bib63","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1563\/AAID-JOI-D-11-00057","article-title":"Development of a rat model of bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"38","author":"Marino","year":"2012","journal-title":"J Oral Implantol"},{"key":"10.1016\/j.joms.2017.04.017_bib64","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.joms.2017.04.017_bib65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.vph.2007.05.004","article-title":"Effect of pentoxifylline on inflammatory burden, oxidative stress and platelet aggregability in hypertensive type 2 diabetes mellitus patients","volume":"47","author":"Maiti","year":"2007","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.joms.2017.04.017_bib66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00000198","article-title":"Effects of pentoxifylline and nabumetone on the serum levels of IL-1beta and TNFalpha in rats with adjuvant arthritis","volume":"49","author":"Silva","year":"2000","journal-title":"Inflamm Res"},{"key":"10.1016\/j.joms.2017.04.017_bib67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12950-015-0080-5","article-title":"Pentoxifylline reduces the inflammatory process in diabetic rats: Relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase","volume":"12","author":"Garcia","year":"2015","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.joms.2017.04.017_bib68","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0722.2005.00216.x","article-title":"Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters","volume":"113","author":"Lima","year":"2005","journal-title":"Eur J Oral Sci"},{"key":"10.1016\/j.joms.2017.04.017_bib69","first-page":"162","article-title":"Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats","volume":"75","author":"Lima","year":"2004","journal-title":"J\u00a0Periodontol"},{"key":"10.1016\/j.joms.2017.04.017_bib70","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.otohns.2003.08.015","article-title":"Prophylactic effect of pentoxifylline on radiotherapy complications: A clinical study","volume":"130","author":"Aygenc","year":"2004","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.joms.2017.04.017_bib71","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00000421-200108000-00010","article-title":"A pilot study of pentoxifylline in the treatment of radiation-induced trismus","volume":"24","author":"Chua","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.joms.2017.04.017_bib72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","article-title":"The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: So many hypotheses, so few data","volume":"67","author":"Allen","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2017.04.017_bib73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05835.x","article-title":"Potential pathophysiological mechanisms in osteonecrosis of the jaw","volume":"1218","author":"Landesberg","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.joms.2017.04.017_bib74","article-title":"Bisphosphonate complications including osteonecrosis of the jaw","volume":"356","author":"Mehrotra","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.joms.2017.04.017_bib75","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.joms.2017.04.017_bib76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejcb.2005.09.004","article-title":"Masters and servants of the force: The role of matrix adhesions in myofibroblast force perception and transmission","volume":"85","author":"Hinz","year":"2006","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.joms.2017.04.017_bib77","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jdermsci.2005.09.002","article-title":"Modeling dermal granulation tissue with the linear fibroblast-populated collagen matrix: A comparison with the round matrix model","volume":"41","author":"Eichler","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.joms.2017.04.017_bib78","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejphar.2012.11.024","article-title":"Pentoxifylline improves cutaneous wound healing in streptozotocin-induced diabetic rats","volume":"700","author":"Babaei","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.joms.2017.04.017_bib79","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2353\/ajpath.2010.090592","article-title":"Bisphosphonates cause osteonecrosis of the jaw-like disease in mice","volume":"177","author":"Bi","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joms.2017.04.017_bib80","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.oraloncology.2008.04.013","article-title":"Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients","volume":"45","author":"Sonis","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.joms.2017.04.017_bib81","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.joms.2011.02.059","article-title":"Perioperative antibiotic regimen in rats treated with pamidronate plus dexamethasone and subjected to dental extraction: A study of the changes in the jaws","volume":"69","author":"Lopez-Jornet","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2017.04.017_bib82","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/odi.12067","article-title":"Animal models for bisphosphonate-related osteonecrosis of the jaws\u2014An appraisal","volume":"19","author":"Sharma","year":"2013","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2017.04.017_bib83","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","article-title":"Non-exposed variant of bisphosphonate-associated osteonecrosis of the jaw: A case series","volume":"123","author":"Fedele","year":"2010","journal-title":"Am J Med"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239117304731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239117304731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:53:56Z","timestamp":1759510436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239117304731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":83,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0278239117304731"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2017.04.017","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventive Effect of Phosphodiesterase Inhibitor Pentoxifylline Against Medication-Related Osteonecrosis of the Jaw: An Animal Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2017.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}